NittoPhase™ solid support utilizes state-of-the-art polymer synthesis capabilities to provide a solid support for therapeutic oligonucleotide synthesis offering the highest available performance at a greatly reduced cost. The superior properties of Nitto’s proprietary formulated cross-linked polystyrene structure deliver increased yields with greater purity at lower unit cost. NittoPhase™ thus delivers a positive impact on both the overall cost and quality of both small and large scale oligonucleotide synthesis.
NittoPhase™ is available as a fully derivatized support, loaded to customer specifications.
Nitto Denko Corporation and its subsidiary Nitto Denko Technical Corporation, a dedicated research and development facility in Oceanside, CA, have applied their unparalleled polymer synthesis expertise to create a solid support product that will deliver higher performance at a lower cost to users. Nitto’s in-house manufacturing and nucleoside loading facilities have the capability to produce supports from laboratory to commercial scale, tailored precisely to customer requirements.